aTyr Pharma (LIFE) Reports Q2 Loss of $0.74/Share

aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.74), versus ($6.85) reported last year.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
• MakeMyTrip (MMYT) PT Raised to $84 at Goldman Sachs